NCT00407264View on ClinicalTrials.gov

Randomized Trial of Fluticasone in Bronchial Premalignancy

PHASE2CompletedINTERVENTIONAL

Enrollment

90

Participants

Timeline

Start Date

February 28, 2002

Study Completion Date

December 31, 2005

Conditions

Bronchogenic Carcinoma

Interventions

DRUG

Fluticasone propionate

Trial Locations (2)

1066CX

the Netherlands Cancer Institute / Antoni van Leeuwenhoek Hospital, Amsterdam

1081HV

VU medical center, Amsterdam

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

collaborator

The Netherlands Cancer Institute

OTHER

lead

Amsterdam UMC, location VUmc

OTHER